MLYS Operating Cash Flow (Statement)
Mineralys Therapeutics Inc · Operating Cash Flow (Statement)
MLYS Operating Cash Flow (Statement)
Latest reported-$138.79Mperiod ending
MLYS TTM Cash from Operations (-$23.93M → -$138.79M)
TTM operating cash flow (statement)
High-resolution chart · PNG
MLYS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -138,786,999 | |
| -136,400,000 | |
| -142,416,000 | |
| -171,371,000 | |
| -192,685,000 | |
| -192,662,000 | |
| -166,314,000 | |
| -128,452,000 | |
| -97,297,000 | |
| -87,537,000 | |
| -81,173,000 | |
| -62,378,000 | |
| -50,335,000 | |
| -35,418,000 | |
| -29,221,000 | |
| -23,925,000 |